[Human plasma gamma globulin injectable by intravenous route].
D000818:Animals; D000906:Antibodies; D000937:Antigen-Antibody Reactions; D001249:Asthma / Q000188:drug therapy; D001665:Binding Sites; D002056:Burns / Q000188:drug therapy; D003165:Complement System Proteins / Q000378:metabolism; D003677:Deficiency Diseases / Q000188:drug therapy; D004899:Erythroblastosis, Fetal / Q000188:drug therapy; D005260:Female; D005341:Fibrinolysin / Q000378:metabolism; D006801:Humans; D007122:Immunoelectrophoresis; D007239:Infections / Q000188:drug therapy; D007275:Injections, Intravenous; D010434:Pepsin A / Q000378:metabolism; D011247:Pregnancy; D011865:Radioisotope Dilution Technique; D005719:gamma-Globulins / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism
D000906:Antibodies; D005719:gamma-Globulins; D003165:Complement System Proteins; D005341:Fibrinolysin; D010434:Pepsin A
Les gammaglobulines plasmatiques humaines injectables par voie intraveineuse.